Evolent Health Inc (EVH) General Counsel Sells $406,800.00 in Stock

Share on StockTwits

Evolent Health Inc (NYSE:EVH) General Counsel Jonathan Weinberg sold 15,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 13th. The shares were sold at an average price of $27.12, for a total transaction of $406,800.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

NYSE:EVH opened at $27.65 on Friday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 2.59 and a current ratio of 2.59. Evolent Health Inc has a one year low of $10.30 and a one year high of $28.20. The company has a market cap of $2.06 billion, a P/E ratio of -39.50 and a beta of 1.22.

Evolent Health (NYSE:EVH) last posted its earnings results on Tuesday, August 7th. The technology company reported ($0.03) EPS for the quarter, topping the consensus estimate of ($0.04) by $0.01. Evolent Health had a negative net margin of 9.84% and a negative return on equity of 1.82%. The business had revenue of $144.51 million for the quarter, compared to the consensus estimate of $141.90 million. analysts expect that Evolent Health Inc will post -0.35 earnings per share for the current fiscal year.

A number of large investors have recently bought and sold shares of the stock. Metropolitan Life Insurance Co. NY boosted its position in Evolent Health by 12.6% during the 2nd quarter. Metropolitan Life Insurance Co. NY now owns 22,031 shares of the technology company’s stock worth $464,000 after buying an additional 2,459 shares during the period. State Board of Administration of Florida Retirement System boosted its position in Evolent Health by 16.9% during the 2nd quarter. State Board of Administration of Florida Retirement System now owns 21,773 shares of the technology company’s stock worth $458,000 after buying an additional 3,150 shares during the period. Legal & General Group Plc boosted its position in Evolent Health by 16.8% during the 1st quarter. Legal & General Group Plc now owns 26,437 shares of the technology company’s stock worth $377,000 after buying an additional 3,811 shares during the period. Rhumbline Advisers boosted its position in Evolent Health by 8.2% during the 1st quarter. Rhumbline Advisers now owns 57,923 shares of the technology company’s stock worth $825,000 after buying an additional 4,370 shares during the period. Finally, Swiss National Bank boosted its position in Evolent Health by 4.8% during the 1st quarter. Swiss National Bank now owns 104,000 shares of the technology company’s stock worth $1,482,000 after buying an additional 4,800 shares during the period.

A number of equities research analysts have recently weighed in on the stock. Canaccord Genuity raised their price target on shares of Evolent Health from $24.00 to $28.00 and gave the company a “buy” rating in a research note on Thursday. ValuEngine upgraded shares of Evolent Health from a “buy” rating to a “strong-buy” rating in a research note on Friday. KeyCorp restated an “overweight” rating and issued a $32.00 price target (up from $28.00) on shares of Evolent Health in a research note on Thursday. They noted that the move was a valuation call. Cantor Fitzgerald restated a “buy” rating and issued a $37.00 price target on shares of Evolent Health in a research note on Wednesday. Finally, MED raised their price target on shares of Evolent Health from $22.00 to $31.00 and gave the company an “outperform” rating in a research note on Monday, June 18th. One investment analyst has rated the stock with a sell rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $28.67.

Evolent Health Company Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management.

Read More: Book Value Per Share – BVPS

Insider Buying and Selling by Quarter for Evolent Health (NYSE:EVH)

Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply